Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Plos One|June 13, 2014
MicroRNA profiles discriminate among colon cancer metastasisAlessandra Drusco, Gerard J Nuovo, Nicola Zanesi, et al.
Oncoimmunology|October 6, 2018
Daratumumab induces CD38 internalization and impairs myeloma cell adhesionJayeeta Ghose, Domenico Viola, Cesar Terrazas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple MyelomaXiuli Wang, Miriam Walter, Ryan Urak, et al.
The Journal of Biological Chemistry|March 6, 2008
Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cellsFrancesco Trapasso, Flavia Pichiorri, Marco Gaspari, et al.
Leukemia & Lymphoma|April 10, 2020
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 studyMichael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, et al.
Blood|January 12, 2008
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemiaRamiro Garzon, Stefano Volinia, Chang-Gong Liu, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemiaMariam Murtadha, Miso Park, Yinghui Zhu, et al.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Clinical and Translational Medicine|October 28, 2021
Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cellsHuafeng Wang, Jie Sun, Bin Zhang, et al.
Cancer Cell|October 19, 2010
RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma developmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Pageof 9